Eiger BioPharma: Q3 Earnings Snapshot
In this article:
PALO ALTO, Calif. (AP) — PALO ALTO, Calif. (AP) — Eiger BioPharmaceuticals Inc. (EIGR) on Thursday reported a loss of $18 million in its third quarter.
On a per-share basis, the Palo Alto, California-based company said it had a loss of 41 cents.
The biopharmaceutical company posted revenue of $3.2 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EIGR at https://www.zacks.com/ap/EIGR
